The Master Program in Medical biotechnology and molecular medicine is committed to form professionals, provided with a strong technical and theoretical background in order to develop scientific methodologies and coordinate research projects in the fields of applied biotechnology and translational medicine.

The Master program will provide students with a strong educational background on the genetic and molecular bases of diseases and the pathophysiological mechanisms that take place in the sick human organism, in order to develop diagnostic and therapeutic strategies based on biotechnology.

This knowledge will be integrated with a specific formation in the fields of informatics, biophysics, nanotechnology and pharmacology. The Master Program is organized in common and curricular learning with insights into neuroscience, oncology, molecular diagnostics and immunobiotechnology. The students will also learn about economic management of a scientific project, with emphasis on the construction of the business plan and cost analysis.

The second year of the course is almost entirely dedicated to research activities, finalized to generate useful data for the preparation of the final exam.

The graduate in the Master Program in Medical biotechnology and molecular medicine will be able to coordinate research projects in the field of biotechnology and molecular medicine and to collaborate with physicians in the development of novel and innovative diagnostic and therapeutic strategies. The graduate, therefore, will find employment as:

• researcher in the fields of medical biotechnology and molecular medicine;
• medical science liaison (MSL);
• clinical Monitor;  market access manager;
• medical and scientific communication advisor.

Enviroment statistics (Almalaurea)

Applications and admissions: with mandatory access test.

To be admitted to the entrance test, the candidates must possess 180 ects obtained in the Bachelor's degree, of which 50 in the following sectors: BIO/09 (Physiology), BIO/10 (Biochemistry), BIO/11 (Molecular biology), BIO/12 (Clinical biochemistry), BIO/13 (Biology), BIO/14 (Pharmacology), BIO/16 (Human anatomy), BIO/18 (Genetics), BIO/19 (General microbiology), MED/01 (Medical statistics), MED/03 (Human genetics) MED/04 (General pathology and immunology), MED/05 (Clinical pathology), MED/06 (Medical oncology), MED/07 (Microbiology), MED/08 (Pathology), MED/09 (Internal medicine), MED/25 (Mental health), MED/26 (Neurology), MED/46 (Laboratory medicine), INF/01 (Informatics), FIS/07 (Medical physics).

The candidate should have a good knowledge of spoken and written English, B2 level is required and the certification has to be provided at the registration of the admission test. Bachelor's students getting their degree by December 31th can participate to the test, they will be accepted, in case of success, if they possess the prerequisites described above.

The test will be in English and will include questions on topics such as biology, biochemistry, physics, pharmacology, immunology, pathology, genetics.

The Master programme in Medical Biotechnology and Molecular Medicine supports cooperation opportunities and mobility with leading international universities, as well as the possibility for students to earn credits through exchange education and training programmes with Partner organizations.

Bilateral agreements with the University of Leuven (Katolieke Universiteit Leuven, Belgium), the LUMC (Leids Universitair Medish Centrum) of the University of Leiden (Netherland) and the University of Cantabria (Universidad de Cantabria, Spain) are and have been active for several years in the framework of the Erasmus + programme. In recent years, a growing number of students have developed their professionalism and the European dimension of their training through residence periods abroad. Associated universities represent highly recognized European institutions, featuring reference schools (Master and PhD schools) in biomedical sciences.

The students will thus be offered exciting opportunities to enhance their CVs and evaluate their interests in extending their careers in the international setting.

5 positions are available for the Academic Year 2019-2020.

The Master course in Medical Biotechnology and Molecular Medicine offers second year students the possibility to carry out the entire practical training for the preparation of their final thesis work in one of the aforementioned institutions or with other institutions with which an agreement has been established. The student will have to define a research project related to his/her course of studies and curricular training, with the joint agreement of both the Unimi and the foreign tutors. The period abroad amounts to 9 months equivalent to 32 credits. A positive evaluation of the period abroad will be required. The latter should be defined by the tutor in the foreign university, the UNIMI tutor and is subjected to the approval by the Unimi Didactic Council. Erasmus students who obtain outstanding results, proved by an official evaluation letter of the foreign tutor to the President of the Masters Commission, will be rewarded with 1-2 additional points in the final Laurea Grade.

Besides general informative meetings organized by the University, the Degree course in Medical Biotechnology provides specific support to interested students. Furthermore, the international programme provides the possibility to access the Erasmus + programme.

Compulsory